Pan M, Zhang Y, Wright W, Liu X, Passaia B, Currier D
Nat Commun. 2025; 16(1):2036.
PMID: 40021625
PMC: 11871043.
DOI: 10.1038/s41467-025-57185-y.
Makimoto A, Fujisaki H, Matsumoto K, Takahashi Y, Cho Y, Morikawa Y
Cancers (Basel). 2024; 16(3).
PMID: 38339295
PMC: 10854948.
DOI: 10.3390/cancers16030544.
Karapurkar J, Kim M, Colaco J, Suresh B, Sarodaya N, Kim D
J Exp Clin Cancer Res. 2023; 42(1):121.
PMID: 37170124
PMC: 10176696.
DOI: 10.1186/s13046-023-02694-1.
Zage P, Huo Y, Subramonian D, Le Clorennec C, Ghosh P, Sahoo D
Genes Chromosomes Cancer. 2023; 62(6):313-331.
PMID: 36680522
PMC: 10257350.
DOI: 10.1002/gcc.23124.
Bartolucci D, Montemurro L, Raieli S, Lampis S, Pession A, Hrelia P
Cancers (Basel). 2022; 14(18).
PMID: 36139583
PMC: 9496712.
DOI: 10.3390/cancers14184421.
Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma.
Yan H, Zhai B, Yang F, Chen Z, Zhou Q, Paiva-Santos A
Front Pharmacol. 2022; 13:908713.
PMID: 35721107
PMC: 9201105.
DOI: 10.3389/fphar.2022.908713.
Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastoma.
Zimmerman M, Durbin A, He S, Oppel F, Shi H, Tao T
Sci Adv. 2021; 7(43):eabe0834.
PMID: 34669465
PMC: 8528416.
DOI: 10.1126/sciadv.abe0834.
CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic Reprogramming.
Tao L, Moreno-Smith M, Ibarra-Garcia-Padilla R, Milazzo G, Drolet N, Hernandez B
Adv Sci (Weinh). 2021; 8(19):e2005047.
PMID: 34365742
PMC: 8498874.
DOI: 10.1002/advs.202005047.
Perspective on Similarities and Possible Overlaps of Congenital Disease Formation-Exemplified on a Case of Congenital Diaphragmatic Hernia and Neuroblastoma in a Neonate.
Huo Z, Bilang R, Brantner B, von der Weid N, Holland-Cunz S, Gros S
Children (Basel). 2021; 8(2).
PMID: 33671521
PMC: 7926624.
DOI: 10.3390/children8020163.
The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma.
Nguyen R, Houston J, Chan W, Finkelstein D, Dyer M
Cancer Immunol Immunother. 2018; 67(4):615-626.
PMID: 29327110
PMC: 5862751.
DOI: 10.1007/s00262-017-2108-6.
Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
Yao P, Chen L, Dobrzanski T, Zhu B, Kang B, Muller R
Mol Carcinog. 2016; 56(5):1472-1483.
PMID: 27996177
PMC: 6361394.
DOI: 10.1002/mc.22607.
Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
Sheikh A, Takatori A, Hossain M, Hasan M, Tagawa M, Nagase H
Cancer Sci. 2016; 107(9):1223-32.
PMID: 27357360
PMC: 5021041.
DOI: 10.1111/cas.13003.
Regulation of microRNAs by natural agents: new strategies in cancer therapies.
Phuah N, Hasima Nagoor N
Biomed Res Int. 2014; 2014:804510.
PMID: 25254214
PMC: 4165563.
DOI: 10.1155/2014/804510.
Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma.
Sonawane P, Cho H, Tagde A, Verlekar D, Yu A, Reynolds C
Br J Pharmacol. 2014; 171(23):5330-44.
PMID: 25039756
PMC: 4294043.
DOI: 10.1111/bph.12846.
Evaluation of the retinoids with cisplatin and vincristine in xenograft models of neuroblastoma.
Norris R, Nguyen V, Adamson P
J Pediatr Hematol Oncol. 2013; 36(1):e23-7.
PMID: 23669732
PMC: 3766379.
DOI: 10.1097/MPH.0b013e3182915d4a.
Targeted isotretinoin in neuroblastoma: kinetics, genetics, or absorption.
Matthay K
Clin Cancer Res. 2012; 19(2):311-3.
PMID: 23209029
PMC: 5892183.
DOI: 10.1158/1078-0432.CCR-12-3313.
Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells.
Chakrabarti M, Khandkar M, Banik N, Ray S
Brain Res. 2012; 1454:1-13.
PMID: 22498172
PMC: 3335959.
DOI: 10.1016/j.brainres.2012.03.017.
Retinoic acid-induced differentiation increases the rate of oxygen consumption and enhances the spare respiratory capacity of mitochondria in SH-SY5Y cells.
Xun Z, Lee D, Lim J, Canaria C, Barnebey A, Yanonne S
Mech Ageing Dev. 2012; 133(4):176-85.
PMID: 22336883
PMC: 3357086.
DOI: 10.1016/j.mad.2012.01.008.
Neuroblastoma.
Davidoff A
Semin Pediatr Surg. 2012; 21(1):2-14.
PMID: 22248965
PMC: 3261589.
DOI: 10.1053/j.sempedsurg.2011.10.009.
Retinoic acid pathway activity in Wilms tumors and characterization of biological responses in vitro.
Wegert J, Bausenwein S, Kneitz S, Roth S, Graf N, Geissinger E
Mol Cancer. 2011; 10:136.
PMID: 22067876
PMC: 3239322.
DOI: 10.1186/1476-4598-10-136.
